Iterum Therapeutics plc — Director's Dealing 2021

Mar 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2021-03-11

Reporting Person: Fishman Corey N. (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-11	Restricted Share Units	$	A	430000	Acquired		Ordinary Shares (430000)	Direct

Footnotes

F1: Each restricted share unit("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.

F2: Subject to the reporting person providing continuous service to the Issuer on the relevant vesting date and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest 50% on March 11, 2022 and 50% on March 11, 2023.